Current Applications for Overcoming Resistance to Targeted Therapies
Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. Howev...
Corporate Author: | |
---|---|
Other Authors: | , , |
Language: | English |
Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Edition: | 1st ed. 2019. |
Series: | Resistance to Targeted Anti-Cancer Therapeutics,
20 |
Subjects: | |
Online Access: | https://doi.org/10.1007/978-3-030-21477-7 |